Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Commercial physical research
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:SNMX
CUSIPN/A
Phone858-646-8300
Debt
Debt-to-Equity RatioN/A
Current Ratio4.35
Quick Ratio3.92
Price-To-Earnings
Trailing P/E Ratio-49.20
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$29.32 million
Price / Sales2.43
Cash FlowN/A
Price / CashN/A
Book Value$0.39 per share
Price / Book3.78
Profitability
EPS (Most Recent Fiscal Year)($0.03)
Net Income$-1,260,000.00
Net Margins-9.11%
Return on Equity-15.80%
Return on Assets-10.48%
Miscellaneous
Employees56
Outstanding Shares48,340,000
Market Cap$71.06 million
Senomyx (NASDAQ:SNMX) Frequently Asked Questions
What is Senomyx's stock symbol?
Senomyx trades on the NASDAQ under the ticker symbol "SNMX."
How were Senomyx's earnings last quarter?
Senomyx Inc. (NASDAQ:SNMX) issued its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative net margin of 9.11% and a negative return on equity of 15.80%. View Senomyx's Earnings History.
When is Senomyx's next earnings date?
Who are some of Senomyx's key competitors?
Some companies that are related to Senomyx include HedgePath Pharmaceuticals (HPPI), Anavex Life Sciences (AVXL), Luna Innovations (LUNA), Vitality Biopharma (VBIO), Dyadic International (DYAI), BIOQUAL (BIOQ), Cleveland BioLabs (CBLI), Bioanalytical Systems (BASI), US Stem Cell (USRM), Protalex (PRTX), Tenax Therapeutics (TENX), Geovax Labs (GOVX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC).
Who are Senomyx's key executives?
Senomyx's management team includes the folowing people:
- Mr. John W. Poyhonen, Pres, CEO & Director (Age 58)
- Mr. David C. Humphrey, VP & CFO (Age 49)
- Ms. Catherine C. Lee, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)
- Ms. Sharon Wicker, Sr. VP & Chief Commercial Devel. Officer (Age 62)
- Ms. Susan Firestone Melody, VP of HR
Has Senomyx been receiving favorable news coverage?
Press coverage about SNMX stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Senomyx earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news coverage about the specialty chemicals company an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for Senomyx.
Who are Senomyx's major shareholders?
Senomyx's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.20%), Renaissance Technologies LLC (1.96%), Algert Global LLC (0.99%), Cowen Prime Services LLC (0.96%) and Quantum Capital Management (0.83%). Company insiders that own Senomyx stock include John Poyhonen, Mary Ann Gray and Senvest Management, Llc. View Institutional Ownership Trends for Senomyx.
Which major investors are selling Senomyx stock?
Which major investors are buying Senomyx stock?
SNMX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Quantum Capital Management and Renaissance Technologies LLC. Company insiders that have bought Senomyx stock in the last two years include John Poyhonen and Mary Ann Gray. View Insider Buying and Selling for Senomyx.
How do I buy shares of Senomyx?
Shares of SNMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Senomyx's stock price today?
One share of SNMX stock can currently be purchased for approximately $1.4760.
How big of a company is Senomyx?
Senomyx has a market capitalization of $71.06 million and generates $29.32 million in revenue each year. The specialty chemicals company earns $-1,260,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Senomyx employs 56 workers across the globe.
How can I contact Senomyx?
Senomyx's mailing address is 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA, 92121. The specialty chemicals company can be reached via phone at 858-646-8300 or via email at [email protected]
MarketBeat Community Rating for Senomyx (NASDAQ SNMX)
MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe SNMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
